Monoclonal antibodies against claudin18 for treatment of cancer

Details for Australian Patent Application No. 2008256489 (hide)

Owner Ganymed Pharmaceuticals AG Johannes Gutenberg-Universitat Mainz

Inventors Sahin, Ugur; Tureci, Ozlem; Brandenburg, Gunda; Usener, Dirk

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008256489

PCT Pub. Number WO2008/145338

Priority 60/932,099 29.05.07 US; 07010622.4 29.05.07 EP

Filing date 27 May 2008

Wipo publication date 4 December 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/12 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Fused cells, e.g. hybridomas

Event Publications

17 December 2009 PCT application entered the National Phase

  PCT publication WO2008/145338 Priority application(s): WO2008/145338

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008256510-Method and apparatus for the surface modification of flat substrates

2008256488-A method for interference estimation for orthogonal pilot patterns